1-6 of 6
Christopher J Burns
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents

Malte Asshoff, Verena Petzer, Matthew R. Warr, David Haschka, Piotr Tymoszuk, Egon Demetz, Markus Seifert, Wilfried Posch, Manfred Nairz, Pat Maciejewski, Peter Fowles, Christopher J. Burns, Gregg Smith, Kay-Uwe Wagner, Guenter Weiss, J. Andrew Whitney, Igor Theurl
Journal: Blood
Blood (2017) 129 (13): 1823–1830.
https://doi.org/10.1182/blood-2016-09-740092
Published: 2017
Includes: Supplemental data
Journal Articles

Effect Of The JAK1/2 Inhibitor GS-0387 (momelotinib) On The Anemia Associated With a Preclinical Murine Model Of Human Primary Myelofibrosis

Jean-Luc Villeval, PhD, Claudine Moratal, M2, Franck Debeurme, Catherine Lacout, Eric Solary, MD, PhD, William Vainchenker, MD, PhD, Christopher J Burns, PhD, Gregg Smith, PhD
Journal: Blood
Blood (2013) 122 (21): 2851.
https://doi.org/10.1182/blood.V122.21.2851.2851
Published: 2013
Journal Articles

CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms

Jeffrey W. Tyner, Thomas G. Bumm, Jutta Deininger, Lisa Wood, Karl J. Aichberger, Marc M. Loriaux, Brian J. Druker, Christopher J. Burns, Emmanuelle Fantino, Michael W. Deininger
Journal: Blood
Blood (2010) 115 (25): 5232–5240.
https://doi.org/10.1182/blood-2009-05-223727
Published: 2010
Includes: Supplemental data
Journal Articles

Tumor Necrosis Factor-Alpha (TNF) Expression Is Elevated in Myelo-Proliferative Neoplasms (MPN) and Modulated by Inhibition of JAK2 V617F.

Karl J. Aichberger, MD, PhD, Angela G. Fleischman, MD, PhD, Shirin Doratotaj, MD, Thomas G.P. Bumm, MD, Richard T. Silver, MD, Thomas G. Deloughery, MD, Heike L. Pahl, PhD, Brian J. Druker, MD, Christopher J. Burns, Michael Deininger, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2917.
https://doi.org/10.1182/blood.V114.22.2917.2917
Published: 2009
Journal Articles

Effects of CYT387, a Potent Novel JAK2 Inhibitor on JAK2-V617F Induced MPD

Thomas G.P. Bumm, Jeffrey W Tyner, PhD, Jutta Deininger, Marc Loriaux, Jonathan VanDyke, Brian J. Druker, Christopher J Burns, Emmanuelle Fantino3, Michael W.N. Deininger, MD
Journal: Blood
Blood (2008) 112 (11): 856.
https://doi.org/10.1182/blood.V112.11.856.856
Published: 2008
Journal Articles

The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor

Isabelle S. Lucet, Emmanuelle Fantino, Michelle Styles, Rebecca Bamert, Onisha Patel, Sophie E. Broughton, Mark Walter, Christopher J. Burns, Herbert Treutlein, Andrew F. Wilks, Jamie Rossjohn
Journal: Blood
Blood (2006) 107 (1): 176–183.
https://doi.org/10.1182/blood-2005-06-2413
Published: 2006
Includes: Supplemental data